[ Price : $8.95]
Reese Pharmaceutical Company voluntarily recalls one lot of guaifenesin tablets sold under four brand names because the labels do ...[ Price : $8.95]
FDA warns consumers to stop using Man Up Now capsules due to a Viagra-like ingredient that may cause dangerously low blood pressur...[ Price : $8.95]
FDA accepts for review a Lantheus Medical Imaging supplemental NDA for Definity (perflutren lipid microsphere) injectable suspensi...[ Price : $8.95]
FDA grants final approval to Mylan for its ANDA for nifedipine extended-release tablets to treat hypertension.[ Price : $8.95]
Federal Register Notice: FDA has determined the regulatory review period for Novartis Coartem (artemether/lumefantrine) is 285 day...[ Price : $8.95]
FDA cites as misleading a Watson Pharmaceuticals public bathroom promo that was used to promote Gelnique (oxybutynin chloride).[ Price : $8.95]
Consulting editor John Scharmann reviews the FDA leaderships increasing lack of transparency and suggests it may be a political co...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period set for Sanofi-Aventis Multaq for the purpose of patent exten...